Difficulty: Medium
Average Score: 69%
Practice
The main reason for avoiding the combined administration of levodopa and an inhibitor of both forms of monoamine oxidase is:
Correct answer
B
Rationale
The correct answer is B) Hypertensive emergency. When levodopa, a medication used in the treatment of Parkinson's disease, is combined with a monoamine oxidase inhibitor (MAOI), it can lead to a potentially life-threatening hypertensive crisis. This is due to the inhibition of MAO enzymes, which normally break down tyramine found in certain foods. When MAO is inhibited, tyramine can accumulate and cause a sudden release of norepinephrine, leading to severe hypertension.
Option A) Respiratory depression is not a common side effect of combining levodopa and MAO inhibitors. Levodopa itself may cause some respiratory issues, but not in combination with MAOIs.
Option C) Acute psychotic reactions are also not directly associated with the combination of levodopa and MAO inhibitors. Psychiatric side effects are more commonly seen with other medications used in Parkinson's disease treatment.
Option D) Cardiovascular collapse and CNS depression are not the primary concerns when combining levodopa and MAO inhibitors. While cardiovascular and CNS side effects can occur with these medications individually, the main risk with their combination is hypertensive crisis due to tyramine interaction.
In an educational context, understanding drug interactions is crucial for healthcare professionals to ensure patient safety. Teaching the potential risks and consequences of combining specific medications can help prevent harmful outcomes and promote effective pharmacological management. This case highlights the importance of considering interactions between drugs and how they can impact physiological processes in the body.
Option A) Respiratory depression is not a common side effect of combining levodopa and MAO inhibitors. Levodopa itself may cause some respiratory issues, but not in combination with MAOIs.
Option C) Acute psychotic reactions are also not directly associated with the combination of levodopa and MAO inhibitors. Psychiatric side effects are more commonly seen with other medications used in Parkinson's disease treatment.
Option D) Cardiovascular collapse and CNS depression are not the primary concerns when combining levodopa and MAO inhibitors. While cardiovascular and CNS side effects can occur with these medications individually, the main risk with their combination is hypertensive crisis due to tyramine interaction.
In an educational context, understanding drug interactions is crucial for healthcare professionals to ensure patient safety. Teaching the potential risks and consequences of combining specific medications can help prevent harmful outcomes and promote effective pharmacological management. This case highlights the importance of considering interactions between drugs and how they can impact physiological processes in the body.